AI-Powered Arrhythmia Innovation Center Unveiled in Hangzhou to Advance Next-Gen Healthcare Productivity

Deputy Director Wang Lisheng, on behalf of the District Committee and the District Government, extended congratulations on the establishment of the center. He fully affirmed the preliminary work of all cooperating parties, pointing out that this collaboration is a concrete practice of the concept of "demand-driven and cross-disciplinary synergy." He expressed that as the core area for Hangzhou's artificial intelligence industry, High-tech Zone (Binjiang) will fully support service provision. He looks forward to the center accelerating research and development and transformation, achieving exemplary innovative results.

Academician Wang Jian'an pointed out in his speech that this is a new starting point carrying the original aspiration and dreams. The essence of innovation is to answer questions that others have not answered and solve problems that previous generations have not resolved. In the field of arrhythmia diagnosis and treatment, we must directly face clinical pain points and provide patients with more precise and minimally invasive solutions. He emphasized that Zhejiang University Second Hospital will leverage the advantages of a top clinical diagnosis and treatment center to provide rich clinical data and key issues, forming a joint force with the platform support of the research institute and government policies. Together, they will overcome key AI technologies, accelerate the transformation of results, cultivate interdisciplinary medical-engineering talents, and ultimately benefit a wide range of patients, contributing to the development of China's healthcare industry.

Jian Ji, the standing vice president, pointed out that the establishment of the Innovation Center is a key measure to implement the annual development policy of the institute. He stated that the institute will actively play the role of a platform bridge, focus on clinical practical issues such as intelligent modeling of intracardiac ultrasound, accelerate the transformation of scientific and technological achievements through the deepening of collaborative innovation mechanisms, and contribute to the development of the regional life and health industry.

Yin Jie, representative of the partner company, stated that the innovation center will be built into an open R&D platform driven by clinical needs and characterized by multidisciplinary integration. All parties will jointly promote the deep integration of AI technology with cardiac electrophysiology, develop an intelligent technology system covering the entire diagnosis and treatment cycle, enhance the precision and minimally invasive level of medical services, and better serve patient needs.

The establishment of the Innovation Center marks a crucial step for all parties involved in the "AI + Healthcare" field. From this new starting point, all parties will join hands to move towards innovation, focus on quality to strengthen capabilities, and jointly promote the deep application and innovative breakthroughs of artificial intelligence technology in the diagnosis and treatment of cardiovascular diseases. This effort aims to contribute more significantly to the development of new productivity and the safeguarding of people's health.